Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 106
Titolo Tipologia Data di pubblicazione Autori File
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children with Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study Protocol 01 - Articolo su rivista 2023 Rizzari C.Valsecchi M. G.Biondi A. +
Improved survival and MRD remission with blinatumomab vs. chemotherapy in children with first high-risk relapse B-ALL 01 - Articolo su rivista 2023 Rizzari C. +
Hypersensitivity Reactions to Native E. coli L-asparaginase in Children with Acute Lymphoblastic Leukemia Treated in Trial ALL-BFM 2000: Impact of Treatment Schedule and Type of Glucocorticoid in Induction 01 - Articolo su rivista 2023 Rizzari C.Biondi A.Valsecchi MG. +
Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia 01 - Articolo su rivista 2022 Rizzari C.Conter V. +
NUP214–ABL1 fusion in childhood T-ALL 01 - Articolo su rivista 2022 Rizzari C.Valsecchi M. G. +
Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war 01 - Articolo su rivista 2022 Rizzari C. +
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study 01 - Articolo su rivista 2022 Rizzari C. +
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO 01 - Articolo su rivista 2022 Molinaro A.Zanta D.Rizzari C.Biondi A. +
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial 01 - Articolo su rivista 2022 Rizzari C. +
Daratumumab with or without chemotherapy in relapsed and refractory acute lymphoblastic leukemia. A retrospective observational Campus ALL study 01 - Articolo su rivista 2022 Rizzari C. +
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child 01 - Articolo su rivista 2022 Faraguna M. C.Musto F.Crescitelli V.Fedeli T.Kullmann G.Cattoni A.Dell'acqua F.Rizzari C. +
Pharmacological and clinical monitoring in children with acute lymphoblastic leukemia treated with a biogeneric PEG-l-asparaginase product 01 - Articolo su rivista 2022 Bettini L. R.Amoroso A.Rizzari C. +
FLT3-ITD in Children with Early T-cell Precursor (ETP) Acute Lymphoblastic Leukemia: Incidence and Potential Target for Monitoring Minimal Residual Disease (MRD) 01 - Articolo su rivista 2022 Biondi, AndreaValsecchi, Maria GraziaRizzari, CarmeloConter, ValentinoCazzaniga, Giovanni +
Blinatumomab in Children and Adolescents with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: A Real-Life Multicenter Retrospective Study in Seven AIEOP (Associazione Italiana di Ematologia e Oncologia Pediatrica) Centers 01 - Articolo su rivista 2022 Rizzari C. +
The impact of the EU General Data Protection Regulation on childhood cancer research in Europe 01 - Articolo su rivista 2022 Rizzari C. +
Impact of Antibodies Against Polyethylene Glycol on the Pharmacokinetics of PEGylated Asparaginase in Children with Acute Lymphoblastic Leukaemia: A Population Pharmacokinetic Approach 01 - Articolo su rivista 2022 Rizzari C. +
PAX5 fusion genes are frequent in poor risk childhood acute lymphoblastic leukaemia and can be targeted with BIBF1120 01 - Articolo su rivista 2022 Fazio, GraziaQuadri, ManuelSaitta, ClaudiaPalmi, ChiaraBardini, MichelaSavino, Angela MariaConter, ValentinoRizzari, CarmeloValsecchi, Maria GraziaBiondi, AndreaCazzaniga, Giovanni +
Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort 01 - Articolo su rivista 2022 Brivio, EricaCossio, AndreaPrunotto, GiuliaRizzari, CarmeloBiondi, AndreaConter, ValentinoValsecchi, Maria GraziaBalduzzi, Adriana +
Can recombinant technology address asparaginase Erwinia chrysanthemi shortages? 01 - Articolo su rivista 2021 Rizzari C. +
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 01 - Articolo su rivista 2021 Fazio G.Bardini M.Grioni A.Quadri M.Palmi C.Conter V.Rizzari C.Valsecchi M. G.Biondi A.Cazzaniga G. +
Mostrati risultati da 1 a 20 di 106
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile